Healthcare provider profile · identity verified

Ryan David Whitney, M.D.

Anesthesiology · BROOKLYN, NY · NPI 1356640650

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	463	69
Amlodipine Besylate	Amlodipine Besylate	321	48
Eliquis	Apixaban	303	19
Tamsulosin Hcl	Tamsulosin Hcl	264	31
Metformin Hcl	Metformin Hcl	227	31
Levothyroxine Sodium	Levothyroxine Sodium	209	23
Metoprolol Succinate	Metoprolol Succinate	179	26
Levetiracetam	Levetiracetam	163	20
Losartan Potassium	Losartan Potassium	146	19
Rosuvastatin Calcium	Rosuvastatin Calcium	143	19
Gabapentin	Gabapentin	136	27
Finasteride	Finasteride	135	15
Latanoprost	Latanoprost	125	19
Lactulose	Lactulose	106	22
Januvia	Sitagliptin Phosphate	105	suppressed
Divalproex Sodium	Divalproex Sodium	102	suppressed
Furosemide	Furosemide	99	13
Simvastatin	Simvastatin	99	11
Mirtazapine	Mirtazapine	93	18
Clopidogrel	Clopidogrel Bisulfate	88	15
Pantoprazole Sodium	Pantoprazole Sodium	88	19
Lisinopril	Lisinopril	86	13
Potassium Chloride	Potassium Chloride	86	13
Nifedipine Er	Nifedipine	78	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	71	11
Nuedexta	Dextromethorphan Hbr/Quinidine	69	suppressed
Carvedilol	Carvedilol	66	suppressed
Donepezil Hcl	Donepezil Hcl	66	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	63	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	60	14
Jardiance	Empagliflozin	58	11
Escitalopram Oxalate	Escitalopram Oxalate	57	suppressed
Risperidone	Risperidone	57	suppressed
Memantine Hcl	Memantine Hcl	54	suppressed
Montelukast Sodium	Montelukast Sodium	52	suppressed
Sertraline Hcl	Sertraline Hcl	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	47	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	44	suppressed
Timolol Maleate	Timolol Maleate	43	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Olanzapine	Olanzapine	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Omeprazole	Omeprazole	38	suppressed
Trazodone Hcl	Trazodone Hcl	37	suppressed
Entresto	Sacubitril/Valsartan	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	11
Enalapril Maleate	Enalapril Maleate	33	suppressed
Xarelto	Rivaroxaban	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Nystatin	Nystatin	31	suppressed
Cyclosporine	Cyclosporine	30	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Benztropine Mesylate	Benztropine Mesylate	29	suppressed
Bumetanide	Bumetanide	29	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	29	29
Atenolol	Atenolol	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	27	suppressed
Ammonium Lactate	Ammonium Lactate	26	14
Albuterol Sulfate Hfa	Albuterol Sulfate	25	12
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	25	suppressed
Travoprost	Travoprost	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	24	12
Carbidopa-Levodopa Er	Carbidopa/Levodopa	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Exemestane	Exemestane	23	suppressed
Prednisone	Prednisone	23	suppressed
Restasis	Cyclosporine	23	suppressed
Valsartan	Valsartan	23	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Vraylar	Cariprazine Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Santyl	Collagenase Clostridium Hist.	18	suppressed
Azithromycin	Azithromycin	16	suppressed
Budesonide	Budesonide	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Haloperidol	Haloperidol	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Konvomep	Omeprazole/Sodium Bicarbonate	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Zenpep	Lipase/Protease/Amylase	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Ramipril	Ramipril	13	suppressed
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Admelog	Insulin Lispro	12	suppressed
Allopurinol	Allopurinol	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Levocarnitine	Levocarnitine	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error